152 related articles for article (PubMed ID: 9722548)
1. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.
Gallois C; Habib A; Tao J; Moulin S; Maclouf J; Mallat A; Lotersztajn S
J Biol Chem; 1998 Sep; 273(36):23183-90. PubMed ID: 9722548
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
[TBL] [Abstract][Full Text] [Related]
3. Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer.
Wong BC; Jiang Xh; Fan XM; Lin MC; Jiang SH; Lam SK; Kung HF
Oncogene; 2003 Feb; 22(8):1189-97. PubMed ID: 12606945
[TBL] [Abstract][Full Text] [Related]
4. Salicylate regulates COX-2 expression through ERK and subsequent NF-kappaB activation in osteoblasts.
Chae HJ; Chae SW; Reed JC; Kim HR
Immunopharmacol Immunotoxicol; 2004 Feb; 26(1):75-91. PubMed ID: 15106733
[TBL] [Abstract][Full Text] [Related]
5. Sodium salicylate inhibits expression of COX-2 through suppression of ERK and subsequent NF-kappaB activation in rat ventricular cardiomyocytes.
Kwon KS; Chae HJ
Arch Pharm Res; 2003 Jul; 26(7):545-53. PubMed ID: 12934647
[TBL] [Abstract][Full Text] [Related]
6. Conjugated polyhydroxybenzene derivatives block tumor necrosis factor-alpha-mediated nuclear factor-kappaB activation and cyclooxygenase-2 gene transcription by targeting IkappaB kinase activity.
Chen CC; Chiu KT; Chan ST; Chern JW
Mol Pharmacol; 2001 Dec; 60(6):1439-48. PubMed ID: 11723253
[TBL] [Abstract][Full Text] [Related]
7. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins.
Elsharkawy AM; Wright MC; Hay RT; Arthur MJ; Hughes T; Bahr MJ; Degitz K; Mann DA
Hepatology; 1999 Sep; 30(3):761-9. PubMed ID: 10462383
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-kappa B-dependent signaling pathway that is only partially sensitive to dexamethasone.
Amrani Y; Lazaar AL; Panettieri RA
J Immunol; 1999 Aug; 163(4):2128-34. PubMed ID: 10438953
[TBL] [Abstract][Full Text] [Related]
9. Involvement of nuclear factor-kappaB in endothelin-A-receptor-induced proliferation and inhibition of apoptosis.
Mangelus M; Galron R; Naor Z; Sokolovsky M
Cell Mol Neurobiol; 2001 Dec; 21(6):657-74. PubMed ID: 12043840
[TBL] [Abstract][Full Text] [Related]
10. Induction of cyclooxygenase-2 by platelet-derived growth factor (PDGF) and its inhibition by dexamethasone are independent of NF-kappaB/IkappaB transcription factors.
Goppelt-Struebe M; Rehm M; Schaefers HJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):636-45. PubMed ID: 10882039
[TBL] [Abstract][Full Text] [Related]
11. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
Efsen E; Bonacchi A; Pastacaldi S; Valente AJ; Wenzel UO; Tosti-Guerra C; Pinzani M; Laffi G; Abboud HE; Gentilini P; Marra F
Hepatology; 2001 Mar; 33(3):713-21. PubMed ID: 11230753
[TBL] [Abstract][Full Text] [Related]
12. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells.
Díaz-Cazorla M; Pérez-Sala D; Lamas S
J Am Soc Nephrol; 1999 May; 10(5):943-52. PubMed ID: 10232679
[TBL] [Abstract][Full Text] [Related]
13. Blockade NF-kappaB activation prohibits TNF-alpha-induced cyclooxygenase-2 gene expression in ED27 trophoblast-like cells.
Kniss DA; Rovin B; Fertel RH; Zimmerman PD
Placenta; 2001 Jan; 22(1):80-9. PubMed ID: 11162356
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells.
Lim JW; Kim H; Kim KH
Lab Invest; 2001 Mar; 81(3):349-60. PubMed ID: 11310828
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9.
Shishodia S; Aggarwal BB
Cancer Res; 2004 Jul; 64(14):5004-12. PubMed ID: 15256475
[TBL] [Abstract][Full Text] [Related]
16. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
Shukla S; Gupta S
Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in human tracheal smooth muscle cells: involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-kappaB.
Lin CC; Hsiao LD; Chien CS; Lee CW; Hsieh JT; Yang CM
Cell Signal; 2004 May; 16(5):597-607. PubMed ID: 14751545
[TBL] [Abstract][Full Text] [Related]
18. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1.
Shishodia S; Majumdar S; Banerjee S; Aggarwal BB
Cancer Res; 2003 Aug; 63(15):4375-83. PubMed ID: 12907607
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory action of nitric oxide on circulating tumor necrosis factor-induced NF-kappaB activity and COX-2 transcription in the endothelium of the brain capillaries.
Blais V; Rivest S
J Neuropathol Exp Neurol; 2001 Sep; 60(9):893-905. PubMed ID: 11556546
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Shishodia S; Koul D; Aggarwal BB
J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
